International Journal of Health Care Finance and Economics

Raw citation data, Impact Factor, Immediacy Index, Published documents, Citations received, , Most cited papers , Recent citations and documents published in this series in EconPapers.

Create citation feed for this series

Raw data:
IF AIF DOC CIT D2Y C2Y SC(%) CiY II AII 1996 0.18 0 0 0 0.08 1997 0.21 0 0 0 0.08 1998 0.22 0 0 0 0.1 1999 0.28 0 0 0 0.13 2000 0.37 0 0 0 0.16 2001 0.37 0 0 0 0.16 2002 0.41 0 0 0 0.19 2003 0.42 0 0 0 0.2 2004 0.47 18 27 0 0 0.21 2005 0.17 0.5 17 35 18 3 0 1 0.06 0.23 2006 0.34 0.51 16 14 35 12 0 0.22 2007 0.3 0.4 17 8 33 10 0 8 0.47 0.18 2008 0.06 0.42 18 12 33 2 0 2 0.11 0.21 2009 0.11 0.43 24 9 35 4 0 4 0.17 0.19
IF: Impact Factor: C2Y / D2Y AIF: Average Impact Factor for series in RePEc in year y DOC: Number of documents published in year y CIT: Number of citations to the series in year y D2Y: Number of articles published in y-1 plus y-2 C2Y: Cites in y to articles published in y-1 plus y-2 SC(%): Percentage of selft citations in y to articles published in y-1 plus y-2 CiY: Cites in year y to documents published in year y IdI: Immediacy Index: CiY / Documents.   AII: Average Immediacy Index for series in RePEc in year y
Impact Factor:	Immediacy Index:
Documents published:	Citations received:

Most cited documents in this series:

(1) RePEc:kap:ijhcfe:v:5:y:2005:i:3:p:211-239 The Impact of Subsidized Health Insurance for the Poor: Evaluating the Colombian Experience Using Propensity Score Matching (2005).
Cited: 10 times.

(2) RePEc:kap:ijhcfe:v:7:y:2007:i:4:p:253-267 The organization and financing of end-stage renal disease in Spain (2007).
Cited: 6 times.

(3) RePEc:kap:ijhcfe:v:7:y:2007:i:4:p:233-252 The organization and financing of dialysis and kidney transplantation services in New Zealand (2007).
Cited: 6 times.

(4) RePEc:kap:ijhcfe:v:7:y:2007:i:2:p:171-183 International Study of Health Care Organization and Financing for end-stage renal disease in France (2007).
Cited: 5 times.

(5) RePEc:kap:ijhcfe:v:5:y:2005:i:1:p:5-21 Pricing and Welfare Implications of Parallel Imports in the Pharmaceutical Industry (2005).
Cited: 5 times.

(6) RePEc:kap:ijhcfe:v:4:y:2004:i:3:p:211-230 Changes in Hospital Quality after Conversion in Ownership Status (2004).
Cited: 5 times.

(7) RePEc:kap:ijhcfe:v:10:y:2010:i:2:p:105-147 Employer-sponsored health insurance for early retirees: impacts on retirement, health, and health care (2010).
Cited: 4 times.

(8) RePEc:kap:ijhcfe:v:4:y:2004:i:4:p:343-368 Hospital Competition under Regulated Prices: Application to Urban Health Sector Reforms in China (2004).
Cited: 4 times.

(9) RePEc:kap:ijhcfe:v:7:y:2007:i:4:p:283-299 International Study of Health Care Organization and Financing of renal services in England and Wales (2007).
Cited: 4 times.

(10) RePEc:kap:ijhcfe:v:5:y:2005:i:2:p:127-145 The Sisyphus Syndrome in Health Revisited (2005).
Cited: 4 times.

(11) RePEc:kap:ijhcfe:v:5:y:2005:i:4:p:327-349 Hospital Health Care: Pricing and Quality Control in a Spatial Model with Asymmetry of Information (2005).
Cited: 4 times.

(12) RePEc:kap:ijhcfe:v:4:y:2004:i:2:p:131-157 The Evolving Science of Quality Measurement for Hospitals: Implications for Studies of Competition and Consolidation (2004).
Cited: 3 times.

(13) RePEc:kap:ijhcfe:v:7:y:2007:i:4:p:269-281 The financing and organization of medical care for patients with end-stage renal disease in Sweden (2007).
Cited: 3 times.

(14) RePEc:kap:ijhcfe:v:8:y:2008:i:2:p:87-111 The production of published research by U.S. academic health economists (2008).
Cited: 3 times.

(15) RePEc:kap:ijhcfe:v:5:y:2005:i:2:p:191-204 Negotiation Advantages of Professional Associations in Health Care (2005).
Cited: 3 times.

(16) RePEc:kap:ijhcfe:v:7:y:2007:i:2:p:113-132 The organization and funding of the treatment of end-stage renal disease in Australia (2007).
Cited: 3 times.

(17) RePEc:kap:ijhcfe:v:5:y:2005:i:2:p:147-164 Is Health Care a Luxury? New Evidence from OECD Data (2005).
Cited: 3 times.

(18) RePEc:kap:ijhcfe:v:9:y:2009:i:2:p:117-135 The soft budget constraint syndrome in the hospital sector (2009).
Cited: 3 times.

(19) RePEc:kap:ijhcfe:v:6:y:2006:i:3:p:173-189 Medicare payment changes and nursing home quality: effects on long-stay residents (2006).
Cited: 3 times.

(20) RePEc:kap:ijhcfe:v:4:y:2004:i:1:p:5-26 A Longitudinal Study of Medicaid Payment, Private-Pay Price and Nursing Home Quality (2004).
Cited: 3 times.

(21) RePEc:kap:ijhcfe:v:8:y:2008:i:4:p:225-244 Consumer price sensitivity in Dutch health insurance (2008).
Cited: 3 times.

(22) RePEc:kap:ijhcfe:v:5:y:2005:i:4:p:351-368 Health Insurance Disparities in Traditional and Contingent/Alternative Employment (2005).
Cited: 3 times.

(23) RePEc:kap:ijhcfe:v:9:y:2009:i:1:p:39-57 Service motives and profit incentives among physicians (2009).
Cited: 2 times.

(24) RePEc:kap:ijhcfe:v:4:y:2004:i:1:p:27-41 Estimating the Compensating Differential for Employer-Provided Health Insurance (2004).
Cited: 2 times.

(25) RePEc:kap:ijhcfe:v:4:y:2004:i:2:p:113-130 Competition in Medical Services and the Quality of Care: Concepts and History (2004).
Cited: 2 times.

(26) RePEc:kap:ijhcfe:v:8:y:2008:i:4:p:279-300 The physician-patient relationship revisited: the patient’s view (2008).
Cited: 2 times.

(27) RePEc:kap:ijhcfe:v:6:y:2006:i:2:p:103-117 Provider choice of quality and surplus (2006).
Cited: 2 times.

(28) RePEc:kap:ijhcfe:v:6:y:2006:i:3:p:215-236 Market structure and technology: evidence from the Italian National Health Service (2006).
Cited: 2 times.

(29) RePEc:kap:ijhcfe:v:4:y:2004:i:1:p:65-89 Competition or Coordination in Hospital Markets with Unionised Labour (2004).
Cited: 2 times.

(30) RePEc:kap:ijhcfe:v:5:y:2005:i:1:p:47-73 The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982–2001 (2005).
Cited: 2 times.

(31) RePEc:kap:ijhcfe:v:8:y:2008:i:4:p:245-256 The optimality of hospital financing system: the role of physician–manager interactions (2008).
Cited: 2 times.

(32) RePEc:kap:ijhcfe:v:6:y:2006:i:4:p:300-324 Does certificate of need affect cardiac outcomes and costs? (2006).
Cited: 2 times.

(33) RePEc:kap:ijhcfe:v:4:y:2004:i:2:p:167-192 Tax Incidence and Net Benefits in the Market for Employment-Related Health Insurance: Sensitivity of Estimates to the Incidence of Employer Costs (2004).
Cited: 2 times.

(34) RePEc:kap:ijhcfe:v:9:y:2009:i:1:p:83-112 Utilisation of physician services in the 50+ population: the relative importance of individual versus institutional factors in 10 European countries (2009).
Cited: 2 times.

(35) RePEc:kap:ijhcfe:v:7:y:2007:i:2:p:185-200 International study of health care organization and financing: development of renal replacement therapy in Germany (2007).
Cited: 2 times.

(36) RePEc:kap:ijhcfe:v:4:y:2004:i:4:p:327-342 The Impact of Ownership Conversions on HMO Performance (2004).
Cited: 2 times.

(37) RePEc:kap:ijhcfe:v:6:y:2006:i:4:p:278-289 Managed care and the scale efficiency of US hospitals (2006).
Cited: 1 times.

(38) RePEc:kap:ijhcfe:v:5:y:2005:i:1:p:75-88 Lifetime Cover in Private Insurance Markets (2005).
Cited: 1 times.

(39) RePEc:kap:ijhcfe:v:6:y:2006:i:2:p:131-150 Medicare fees and physicians’ medicare service volume: Beneficiaries treated and services per beneficiary (2006).
Cited: 1 times.

(40) RePEc:kap:ijhcfe:v:4:y:2004:i:4:p:307-326 How did Dentists Respond to the Introduction of Global Budgets in Taiwan? An Evaluation Using Individual Panel Data (2004).
Cited: 1 times.

(41) RePEc:kap:ijhcfe:v:8:y:2008:i:3:p:145-162 Information vs advertising in the market for hospital care (2008).
Cited: 1 times.

(42) RePEc:kap:ijhcfe:v:9:y:2009:i:4:p:367-390 Health insurance and ex ante moral hazard: evidence from Medicare (2009).
Cited: 1 times.

(43) RePEc:kap:ijhcfe:v:6:y:2006:i:3:p:237-258 The impact of government decentralization on county health spending for the uninsured in California (2006).
Cited: 1 times.

(44) RePEc:kap:ijhcfe:v:11:y:2011:i:2:p:115-132 Market power and contract form: evidence from physician group practices (2011).
Cited: 1 times.

(45) RePEc:kap:ijhcfe:v:7:y:2007:i:2:p:149-169 The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care (2007).
Cited: 1 times.

(46) RePEc:kap:ijhcfe:v:4:y:2004:i:3:p:231-246 New Evidence on Hospital Profitability by Payer Group and the Effects of Payer Generosity (2004).
Cited: 1 times.

(47) RePEc:kap:ijhcfe:v:9:y:2009:i:2:p:211-232 The effect of soft budget constraints on access and quality in hospital care (2009).
Cited: 1 times.

(48) RePEc:kap:ijhcfe:v:6:y:2006:i:1:p:25-47 Employer choices of family premium sharing (2006).
Cited: 1 times.

(49) RePEc:kap:ijhcfe:v:11:y:2011:i:1:p:1-34 The quality of medical care, behavioral risk factors, and longevity growth (2011).
Cited: 1 times.

(50) RePEc:kap:ijhcfe:v:8:y:2008:i:1:p:13-26 The effect of physician and health plan market concentration on prices in commercial health insurance markets (2008).
Cited: 1 times.

Recent citations received in: | 2009 | 2008 | 2007 | 2006

Recent citations received in: 2009

(1) RePEc:bol:bodewp:660 Incentives In Primary Care and Their Impact on Potentially Avoidable Hospital Admissions (2009). Working Papers

(2) RePEc:irh:wpaper:dt28 What are the Motivations of Pathways to Retirement in Europe: Individual, Familial, Professional Situation or Social Protection Systems? (2009). Working Papers

(3) RePEc:kap:ijhcfe:v:9:y:2009:i:2:p:211-232 The effect of soft budget constraints on access and quality in hospital care (2009). International Journal of Health Care Finance and Economics

(4) RePEc:kap:ijhcfe:v:9:y:2009:i:2:p:233-242 Soft budget constraints in China: Evidence from the Guangdong hospital industry (2009). International Journal of Health Care Finance and Economics

Recent citations received in: 2008

(1) RePEc:pra:mprapa:23311 Incentive Compatibility and Efficiency in the contractual Insurer-Provider Relationship: Economic Theory and practical Implications: The Case of North Carolina (2008). MPRA Paper

(2) RePEc:wly:hlthec:v:17:y:2008:i:4:p:535-543 US health economists: who we are and what we do (2008). Health Economics

Recent citations received in: 2007

(1) RePEc:kap:ijhcfe:v:7:y:2007:i:2:p:133-148 Belgium’s mixed private/public health care system and its impact on the cost of end-stage renal disease (2007). International Journal of Health Care Finance and Economics

(2) RePEc:kap:ijhcfe:v:7:y:2007:i:2:p:171-183 International Study of Health Care Organization and Financing for end-stage renal disease in France (2007). International Journal of Health Care Finance and Economics

(3) RePEc:kap:ijhcfe:v:7:y:2007:i:2:p:185-200 International study of health care organization and financing: development of renal replacement therapy in Germany (2007). International Journal of Health Care Finance and Economics

(4) RePEc:kap:ijhcfe:v:7:y:2007:i:2:p:73-111 End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF) (2007). International Journal of Health Care Finance and Economics

(5) RePEc:kap:ijhcfe:v:7:y:2007:i:4:p:253-267 The organization and financing of end-stage renal disease in Spain (2007). International Journal of Health Care Finance and Economics

(6) RePEc:kap:ijhcfe:v:7:y:2007:i:4:p:269-281 The financing and organization of medical care for patients with end-stage renal disease in Sweden (2007). International Journal of Health Care Finance and Economics

(7) RePEc:kap:ijhcfe:v:7:y:2007:i:4:p:283-299 International Study of Health Care Organization and Financing of renal services in England and Wales (2007). International Journal of Health Care Finance and Economics

(8) RePEc:nbr:nberwo:13125 End-stage Renal Disease and Economic Incentives: The International Study of Health Care Organization and Financing (2007). NBER Working Papers

Recent citations received in: 2006

Warning!! This is still an experimental service. The results of this service should be interpreted with care, especially in research assessment exercises. The processing of documents is automatic. There still are errors and omissions in the identification of references. We are working to improve the software to increase the accuracy of the results.

Source data used to compute the impact factor of RePEc series.